erythromycin has been researched along with netilmicin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Au, TK; Chan, EW; Chan, RC; Chin, ML; Chow, VC; Fung, DK; Hawkey, PM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Mattie, H | 1 |
| Dournon, E; Rajagopalan, P; Vildé, JL | 1 |
| Nicoletti, G; Russo, G; Stefani, S; Tempera, G | 1 |
| Dibb, WL; Digranes, A; Salveson, A | 1 |
| Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
13 other study(ies) available for erythromycin and netilmicin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Streptococcus | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Erythromycin; Gram-Negative Bacteria; Mice; Netilmicin; Pseudomonas aeruginosa; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
Topics: Anti-Bacterial Agents; Doxycycline; Drug Combinations; Erythromycin; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Pefloxacin; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
New trends in the chemotherapy of staphylococcal infections.
Topics: Anti-Bacterial Agents; Erythromycin; Gentamicins; Humans; Lincomycin; Methicillin; Microbial Sensitivity Tests; Netilmicin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tetracycline | 1986 |
Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
Topics: Aminocoumarins; Ampicillin; Anti-Bacterial Agents; Clindamycin; Cloxacillin; Coumarins; Doxycycline; Erythromycin; Gram-Positive Bacteria; Humans; Netilmicin; Penicillin G; Staphylococcus; Streptococcus; Vancomycin | 1986 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |